The Role of Nitric oxide (NO) Donors in the Treatment of Male Infertility.

Nitric oxide fertilisation capacity male infertility reactive oxygen species reproductive biology. treatment options

Journal

Current pharmaceutical design
ISSN: 1873-4286
Titre abrégé: Curr Pharm Des
Pays: United Arab Emirates
ID NLM: 9602487

Informations de publication

Date de publication:
Historique:
received: 31 03 2020
accepted: 04 08 2020
pubmed: 14 11 2020
medline: 25 2 2023
entrez: 13 11 2020
Statut: ppublish

Résumé

Male infertility is a global problem and the number of men suffering from this condition has increased dramatically over the last decade. Currently, approximately 10-15% of couples have been affected by this worldwide. Although this is a crucial problem, treatment options are limited and sometimes even ineffective. In order to arrest this worrisome increase, the development of new treatment strategies has become fundamental. Redox regulation driven by NO in reproductive biology represents a novel pathway in male infertility and it plays a crucial role in maintaining normal fertilisation capacity. Compelling evidence states that ROS synthesis and degradation should be in perfect balance and tightly regulated by endogenous and exogenous antioxidant enzymes. NO donor drugs might play a beneficial role in restoring this fragile equilibrium and have shown great potential in ameliorating overall fertilisation capacity.

Identifiants

pubmed: 33183193
pii: CPD-EPUB-111462
doi: 10.2174/1381612826666201112144828
doi:

Substances chimiques

Antioxidants 0
Nitric Oxide Donors 0
Reactive Oxygen Species 0
Nitric Oxide 31C4KY9ESH

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2784-2789

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Edoardo Pozzi (E)

Institute of Andrology, University College London Hospital, London, United Kingdom.

Omer Onur Cakir (OO)

Institute of Andrology, University College London Hospital, London, United Kingdom.

Asif Muneer (A)

Institute of Andrology, University College London Hospital, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH